Pehr Lind

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

I defended my doctoral thesis on radition therapy in breast cancer at Karolinska Institutet (KI) Södersjukhuset in 1999. I thereafter did a post-doctoral studies at Duke University North Carolina. Following this I was accepted as Associate Professor of KI. I have tutored five PhDs to graduation.

Forskningsbeskrivning

Clinical radiation therapy including AI, and medical Oncology in GI malignancies.

Undervisning

I defended my doctoral thesis on radition therapy in breast cancer at Karolinska Institutet (KI) Södersjukhuset in 1999. I thereafter did a post-doctoral studies at Duke University North Carolina. Following this I was accepted as Associate Professor of KI. I have tutored five PhDs to graduation.

Artiklar

Journal article: RADIOTHERAPY AND ONCOLOGY. 2025;206:s1170-s1173
1489 STAR-TREC (NCT02945566): A randomised phase II/III trial of CRT versus 5x5 Gy SCRT for organ preservation in early/intermediate risk rectal cancer
Marijnen CAM; Sebag-Montefiore D; Homer V; Gates S; Al-Najami I; Angenete E; Appelt A; Baatrup G; Beets G; Burger JWA; Spindler K-LG; Geh I; Gilbert A; Haustermans K; Holman F; Korsgen S; Lind P; Martling A; Peters F; Teo M; West N; Wolthuis A; de Wilt JWH; ESTRO SPBSCLG
Article: JOURNAL OF CLINICAL ONCOLOGY. 2025;43(10):1240-1253
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Palmer DH; Jackson R; Springfeld C; Ghaneh P; Rawcliffe C; Halloran CM; Faluyi O; Cunningham D; Wadsley J; Darby S; Meyer T; Gillmore R; Lind P; Glimelius B; Falk S; Ma YT; Middleton GW; Cummins S; Ross PJ; Wasan H; Mcdonald A; Crosby T; Hammel P; Borg D; Sothi S; Valle JW; Mehrabi A; Bailey P; Tjaden C; Michalski C; Hackert T; Buechler MW; Neoptolemos JP
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(16_suppl):e15615
Bowel bag sparing in palliative radiotherapy (pRT) of rectal cancer (rCa): Tradeoff between organs at risk (OARs) and use of AI to reduce radiation oncologist (RO) workload.
Fredén E; Knutsson J; Yousif R; Siegbahn A; Lind PA
Journal article: RADIOTHERAPY AND ONCOLOGY. 2024;194:s1491-s1493
723: Delineation variations in RT planning of rectum cancer patients using the Swedish guideline
Fredén E; Knutsson J; Lagerbäck C; Siegbahn A; Lind P
Article: JOURNAL OF SURGICAL ONCOLOGY. 2024;129(4):734-744
The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial
Caspers IA; Slagter AE; Lind P; Sikorska K; Wiklund K; Ponten F; Nordsmark M; van de Velde CJH; Kranenbarg EM-K; van Sandick JW; Jansen EPM; van Laarhoven HWM; Verheij M; van Grieken NCT; Cats A
Article: GASTRIC CANCER. 2024;27(1):102-109
Effect of preoperative chemotherapy on the histopathological classification of gastric cancer
Caspers IA; Biesma HD; Wiklund K; Ponten F; Lind P; Nordsmark M; Sikorska K; Meershoek-KleinKranenbarg E; Hartgrink HH; van de Velde CJH; van Sandick JW; Verheij M; Cats A; van Grieken NCT
Article: CANCERS. 2023;15(24):5736
Dosimetric Comparison of Conventional Radiotherapy, Volumetric Modulated Arc Therapy, and Proton Beam Therapy for Palliation of Thoracic Spine Metastases Secondary to Breast or Prostate Cancer
Lidestahl A; Freden E; Siegbahn A; Johansson G; Lind PA; Ishikawa E; Matschke J; Rueckert M; Deloch L
Journal article: JOURNAL OF RADIOTHERAPY IN PRACTICE. 2022;21(4):455-461
Changes on myocardial perfusion scintigraphy and contrast-enhanced cardiac magnetic resonance imaging after definitive radiotherapy in patients with lung cancer
Lidestahl A; Larsson T; Thoren L; Brodin O; Lind PA
Article: CANCERS. 2022;14(12):2963
Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
Slagter AE; Caspers IA; van Grieken NCT; Walraven I; Lind P; Meershoek-Klein Kranenbarg E; Grootscholten C; Nordsmark M; van Sandick JW; Sikorska K; van de Velde CJH; Jansen EPM; Verheij M; van Laarhoven HWM; Cats A
Article: GASTRIC CANCER. 2022;25(2):401-410
Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial
Slagter AE; Vollebergh MA; Caspers IA; van Sandick JW; Sikorska K; Lind P; Nordsmark M; Putter H; Braak JPBM; Kranenbarg EM-K; van de Velde CJH; Jansen EPM; Cats A; van Laarhoven HWM; van Grieken NCT; Verheij M
Article: CANCERS. 2021;13(20):5153
Estimated Risk of Radiation-Induced Cancer after Thymoma Treatments with Proton- or X-ray Beams
Lidestahl A; Johansson G; Siegbahn A; Lind PA
Article: CANCERS. 2021;13(18):4626
Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial
Caspers IA; Sikorska K; Slagter AE; van Amelsfoort RM; Kranenbarg EM-K; van de Velde CJH; Lind P; Nordsmark M; Jansen EPM; Verheij M; van Sandick JW; Cats A; van Grieken NCT
Journal article: RADIOTHERAPY AND ONCOLOGY. 2021;161:s1513-s1514
PO-1788 Estimated risk of radiation-induced cancer after thymoma treatments with proton- or x-ray beams
Lideståhl A; Johansson G; Siegbahn A; Lind PA
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(15_suppl):4024
The prognostic value of tumor markers in patients (pts) with resectable gastric cancer (GC) receiving perioperative therapy in the CRITICS trial.
Slagter AE; Vollebergh MA; Caspers IA; van Sandick JW; Sikorska K; Lind PA; Nordsmark M; Putter H; Braak JPBM; Kranenbarg EM; Van De Velde CJH; Jansen EP; Cats A; Van Laarhoven HWM; van Grieken NCT; Verheij M
Article: ANNALS OF ONCOLOGY. 2021;32(3):360-367
Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial
de Steur WO; van Amelsfoort RM; Hartgrink HH; Putter H; Kranenbarg EM-K; van Grieken NCT; van Sandick JW; Claassen YHM; Braak JPBM; Jansen EPM; Sikorska K; van Tinteren H; Walraven I; Lind P; Nordsmark M; Henegouwen MIVB; van Laarhoven HWM; Cats A; Verheij M; van de Velde CJH
Article: CANCER MEDICINE. 2020;9(18):6609-6616
Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
Slagter AE; Sikorska K; Grootscholten C; van Laarhoven HWM; Lind P; Nordsmark M; Kranenbarg EM-K; van de Velde CJH; van Grieken NCT; van Sandick JW; Jansen EPM; Verheij M; Cats A
Article: EUROPEAN JOURNAL OF CANCER. 2020;130:146-154
Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial
Slagter AE; Tudela B; van Amelsfoort RM; Sikorska K; van Sandick JW; van de Velde CJH; van Grieken NCT; Lind P; Nordsmark M; Putter H; Hulshof MCCM; van Laarhoven HWM; Grootscholten C; Braak JPBM; Kranenbarg EM-K; Jansen EPM; Cats A; Verheij M
Journal article: EJSO. 2020;46(2):e17
Patterns of recurrence in the CRITICS gastric cancer trial: results from intention-to-treat and per-protocol analyses
De Steur W; Van Amelsfoort R; Putter H; Hartgrink H; Sikorska K; Cats A; van Grieken N; Kranenbarg EM-K; van Sandick J; Lind P; Norsmark M; Verheij M; van de Vede C
Article: JAMA SURGERY. 2019;154(11):1038-1048
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial
Jones RP; Psarelli E-E; Jackson R; Ghaneh P; Halloran CM; Palmer DH; Campbell F; Valle JW; Faluyi O; O'Reilly DA; Cunningham D; Wadsley J; Darby S; Meyer T; Gillmore R; Anthoney A; Lind P; Glimelius B; Falk S; Izbicki JR; Middleton GW; Cummins S; Ross PJ; Wasan H; McDonald A; Crosby T; Ting Y; Patel K; Sherriff D; Soomal R; Borg D; Sothi S; Hammel P; Lerch MM; Mayerle J; Tjaden C; Strobel O; Hackert T; Buchler MW; Neoptolemos JP; Hill M; Corrie P; Hickish T; Napier M; Slater S; Valle J; Shablak A; Cunnell M; Guimbaud R; Roques T; Iveson T; Jamil A; Robinson A; Garcia-Alonso A; Chang D; Tsang D; Wadd N; Wall L; Nielsen NH; Lerch M; Mehta A; Sivaramalingam M; Fyfe D; Osborne R; Blesing C; Bulusu VR; Rathbone E; Seitz J-F; Beaumont E; Dernedde U; McAdam K; Dimopoulos P; Cominos M; Askill C; Piwowar A; Bachet J-B; Sumpter K; Raouf S; Nicoll J; Rees C; Dhinakaran K; Haux J; Bengrine-Lefevre L; Terrebonne E; Shankland C; Palmer C; Medley L; Toy E; Kaur J; Gupta K; Cheeseman S; Patterson D; Candish C; Thompson J; Coxon F; Connolly C; McPhail N; Williams R; Flygare P; Elmlund M; Artru P; Millat B
Article: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2019;60:120-126
An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours
Lidestahl A; Mondlane G; Gubanski M; Lind PA; Siegbahn A
Article: RADIATION ONCOLOGY. 2018;13(1):206
Estimation of the risk for radiation-induced liver disease following photon- or proton-beam radiosurgery of liver metastases
Mondlane G; Ureba A; Gubanski M; Lind PA; Siegbahn A
Article: ANTICANCER RESEARCH. 2018;38(5):2619-2625
Estimation of Risk of Normal-tissue Toxicity Following Gastric Cancer Radiotherapy with Photon- or Scanned Proton-beams
Mondlane G; Ureba A; Gubanski M; Lind PA; Siegbahn A
Article: LANCET ONCOLOGY. 2018;19(5):616-628
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Kranenbarg EM-K; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; Henegouwen MIVB; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M
Article: PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS. 2017;42:263-270
Comparative study of the calculated risk of radiation-induced cancer after photon- and proton-beam based radiosurgery of liver metastases
Mondlane G; Gubanski M; Lind PA; Ureba A; Siegbahn A
Journal article: PANCREATOLOGY. 2017;17(3):s75
Current Treatment Reality of Pancreatic Adenocarcinoma
Kordes M; Liljefors MG; Karimi M; Lind P; Frödin J-E; Löhr M
Article: LANCET. 2017;389(10073):1011-1024
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
Neoptolemos JP; Palmer DH; Ghaneh P; Psarelli EE; Valle JW; Halloran CM; Faluyi O; O'Reilly DA; Cunningham D; Wadsley J; Darby S; Meyer T; Gillmore R; Anthoney A; Lind P; Glimelius B; Falk S; Izbicki JR; Middleton GW; Cummins S; Ross PJ; Wasan H; McDonald A; Crosby T; Ma YT; Patel K; Sherriff D; Soomal R; Borg D; Sothi S; Hammel P; Hackert T; Jackson R; Buechler MW
Article: PRACTICAL RADIATION ONCOLOGY. 2016;6(3):e53-e59
Pulmonary function and cardiac stress test after multimodality treatment of esophageal cancer
von Dobeln GA; Nilsson M; Adell G; Johnsen G; Hatlevoll I; Tsai J; Lundell L; Lund M; Lind P
Article: ANNALS OF ONCOLOGY. 2016;27(4):660-667
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
Klevebro F; von Dobeln GA; Wang N; Johnsen G; Jacobsen A-B; Friesland S; Hatlevoll I; Glenjen NI; Lind P; Tsai JA; Lundell L; Nilsson M
Article: INTERNATIONAL JOURNAL OF PARTICLE THERAPY. 2016;3(2):277-284
Dosimetric Comparison of Plans for Photon- or Proton-Beam Based Radiosurgery of Liver Metastases.
Mondlane G; Gubanski M; Lind PA; Henry T; Ureba A; Siegbahn A
Article: ACTA ONCOLOGICA. 2014;53(10):1373-1379
Long-term functional and radiological pulmonary changes after radiation therapy for breast cancer
Goldman UB; Svane G; Anderson M; Wennberg B; Lind P
Article: JOURNAL OF RADIOTHERAPY IN PRACTICE. 2014;13(2):211-217
Radiation pneumonitis and pulmonary function with lung dose-volume constraints in breast cancer irradiation
Goldman UB; Anderson M; Wennberg B; Lind P
Article: MEDICAL ONCOLOGY. 2014;31(4):906
Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin)
Gubanski M; Glimelius B; Lind PA
Article: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(6):504-512
Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study
Valle JW; Palmer D; Jackson R; Cox T; Neoptolemos JP; Ghaneh P; Rawcliffe CL; Bassi C; Stocken DD; Cunningham D; O'Reilly D; Goldstein D; Robinson BA; Karapetis C; Scarfe A; Lacaine F; Sand J; Izbicki JR; Mayerle J; Dervenis C; Olah A; Butturini G; Lind PA; Middleton MR; Anthoney A; Sumpter K; Carter R; Buecher MW
Article: INTERNATIONAL JOURNAL OF CANCER. 2013;133(9):2245-2252
Cardiac toxicity in breast cancer patients treated with dual HER2 blockade
Valachis A; Nearchou A; Polyzos NP; Lind P
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2013;31(15_suppl):624
Cardiac toxicity in breast cancer patients treated with dual HER2 blockade: A meta-analysis of randomized evidence.
Valachis A; Nearchou AD; Polyzos NP; Lind P
Article: ACTA ONCOLOGICA. 2013;52(4):824-830
Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy
Hultman B; Lind P; Glimelius B; Sundbom M; Nygren P; Haglund U; Mahteme H
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(15_suppl):5066
Effect of BRCA mutation on prognosis in patients with ovarian cancer: A systematic review and meta-analysis.
Valachis A; Polyzos NP; Zavos A; Mauri D; Lind PA
Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(12):1316-1320
Financial Relationships in Economic Analyses of Targeted Therapies in Oncology
Valachis A; Polyzos NP; Nearchou A; Lind P; Mauri D
Journal article: CANCER RESEARCH. 2011;71(24_Supplement):p3-07-34-p3-07-34
P3-07-34: Occult Metastasis in Sentinel Node: Should This Affect the Clinical Decision Making? A Systematic Review and Meta-Analysis.
Valachis A; Nearchou A; Polyzos N; Lind P; Berqvist J
Article: BMC CANCER. 2011;11:329
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
Dikken JL; van Sandick JW; Swellengrebel HAM; Lind PA; Putter H; Jansen EPM; Boot H; van Grieken NCT; van de Velde CJH; Verheij M; Cats A
Article: RADIATION ONCOLOGY. 2010;5:99
Reduction of radiation pneumonitis by V20-constraints in breast cancer
Goldman UB; Wennberg B; Svane G; Bylund H; Lind P
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2010;304(10):1073-1081
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
Neoptolemos JP; Stocken DD; Bassi C; Ghaneh P; Cunningham D; Goldstein D; Padbury R; Moore MJ; Gallinger S; Mariette C; Wente MN; Izbicki JR; Friess H; Lerch MM; Dervenis C; Olah A; Butturini G; Doi R; Lind PA; Smith D; Valle JW; Palmer DH; Buckels JA; Thompson J; McKay CJ; Rawcliffe CL; Buechler MW
Article: GASTRIC CANCER. 2010;13(3):155-161
Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
Gubanski M; Johnsson A; Fernebro E; Kadar L; Karlberg I; Flygare P; Berglund A; Glimelius B; Lind PA
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2010;77(4):1166-1170
INTEROBSERVER VARIATION OF CLINICAL TARGET VOLUME DELINEATION IN GASTRIC CANCER
Jansen EPM; Nijkamp J; Gubanski M; Lind PARM; Verheij M
Article: RADIOTHERAPY AND ONCOLOGY. 2010;95(3):292-297
Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study
Gunnlaugsson A; Anderson H; Lind P; Glimelius B; Johnsson A
Article: LAKARTIDNINGEN. 2007;104(43):3214-3215
[Adjuvant therapy of ventricular cancer tested in Sweden].
Glimelius B; Lind P; Lundell L
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2007;25(18_suppl):15073
Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma
Lind PA; Isaksson B; Almström M; Johnsson A; Albiin N; Byström P; Permert J
Article: RADIOTHERAPY AND ONCOLOGY. 2007;82(3):308-316
Early clinical and radiological breast cancer radiation pulmonary complications following therapy: NTCP fit with four different models
Rancati T; Wennberg B; Lind P; Svane G; Gagliardi G
Article: ACTA ONCOLOGICA. 2007;46(2):230-233
Efficacy of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma
Lind PA; Naucler G; Holm A; Gubanski M; Svensson C
Article: ACTA ONCOLOGICA. 2007;46(2):187-193
Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer
Blom-Goldman U; Svane G; Wennberg B; Lidestahl A; Lind PARM
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2006;24(18_suppl):17059
Cardiac changes on MRI and SPECT after definitive radiotherapy in patients with lung cancer
Lind PA; Larsson T; Lideståhl A; Thoren L; Ågren-Cronqvist A; Nygren AT; Brodin O
Journal article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2004;60:s401
Effect of dose-volume constraints on pneumonitis in loco-regional breast cancer irradiation
BLOMGOLDMAN U; ANDERSON M; WENNBERG B; SVANE G; LIND P
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2004;22(14_suppl):693
Prevention of radiation pneumonitis in breast cancer irradiation through dose-volume constraint
Lind P; Blom-Goldman U; Anderson M; Wennberg B; Svane G
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2004;22(14_suppl):693
Prevention of radiation pneumonitis in breast cancer irradiation through dose-volume constraint
Lind P; Blom-Goldman U; Anderson M; Wennberg B; Svane G
Journal article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2003;57(2):s130
ROC-curves and evaluation of radiation-induced side-effects in breast cancer
Lind PA; Wennberg B; Gagliardi G; Rosfors S; Svane G
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2002;53(4):835-846
Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer.
Etiz D; Marks LB; Zhou S-M; Bentel GC; Clough R; Hernando ML; Lind PA
Article: CANCER. 2002;94(11):2821-2829
Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.
Lind PA; Marks LB; Jamieson TA; Carter DL; Vredenburgh JJ; Folz RJ; Prosnitz LR
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2002;52(5):1196-1206
Early response of lung in breast cancer irradiation: Radiologic density changes measured by CT and symptomatic radiation pneumonitis
Wennberg B; Gagliardi G; Sundbom L; Svane G; Lind P
Journal article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2001;51(3):157-158
Myocardial perfusion changes in patients treated for left-sided breast cancer and correlation with coronary artery distribution
Lind PA; Pagnanelli R; Marks LB; Hu C; Borges-Neto S; Hardenbergh PH
Journal article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2001;51(3):51
Breast conservation rates - barriers between tertiary care and community practice
Hahn CA; Marks LB; Chen DY; Lind PA; Lind HM; Prosnitz LR
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2001;51(3):650-659
Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer.
Hernando ML; Marks LB; Bentel GC; Zhou SM; Hollis D; Das SK; Fan M; Munley MT; Shafman TD; Anscher MS; Lind PA
Article: BREAST CANCER RESEARCH AND TREATMENT. 2001;68(3):199-210
Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose
Lind PARM; Wennberg B; Gagliardi G; Fornander T
Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2001;50(2):421-425
A practical and easy method to locate the first three internal mammary lymph node-bearing areas.
Marks LB; Bentel GC; Hardenbergh PH; Lind PA; Prosnitz LR
Article: EUROPEAN RADIOLOGY. 2000;10(3):484-489
Abnormalities on chest radiographs following radiation therapy for breast cancer
Lind PARM; Bylund H; Wennberg B; Svensson C; Svane G
Journal article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 1999;45(3):316-317
2075 Pulmonary side-effects following radiotherapy in breast cancer and the association to irradiated lung volume
Lind PA; Wennberg B; Svensson C; Fornander T
Article: RADIOTHERAPY AND ONCOLOGY. 1998;49(3):245-254
Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning.
Lind PA; Rosfors S; Wennberg B; Glas U; Bevegård S; Fornander T
Article: ACTA ONCOLOGICA. 1997;36(5):509-515
A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer
Lind PARM; Gagliardi G; Wennberg B; Fornander T
Visa fler

Alla övriga publikationer

Conference publication: RADIOTHERAPY AND ONCOLOGY. 2025;206:S1170-S1173
STAR-TREC (NCT02945566): A randomised phase II/III trial of CRT versus 5x5 Gy SCRT for organ preservation in early/intermediate risk rectal cancer
Marijnen CAM; Sebag-Montefiore D; Homer V; Gates S; Al-Najami I; Angenete E; Appelt A; Baatrup G; Beets G; Burger JWA; Spindler K-LG; Geh I; Gilbert A; Haustermans K; Holman F; Korsgen S; Lind P; Martling A; Peters F; Teo M; West N; Wolthuis A; de Wilt JWH; Bach SP
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(16)
Bowel bag sparing in palliative radiotherapy (pRT) of rectal cancer (rCa): Tradeoff between organs at risk (OARs) and use of AI to reduce radiation oncologist (RO) workload
Freden E; Knutsson J; Yousif R; Siegbahn A; Lind PA
Review: ACTA ONCOLOGICA. 2022;61(4):523-530
Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives
Merk C; Martling A; Lindberg J; Benhaim L; Taieb J; Lind P
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2021;161:S306-S307
The prognostic value of tumor markers in patients with resectable gastric cancer
Slagter A; Vollebergh M; Caspers I; van Sandick J; Sikorska K; Lind P; Nordsmark M; Putter H; Braak J; Kranenbarg EM-K; van de Velde C; Jansen E; Cats A; van Laarhoven H; van Grieken N; Verheij M
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2021;161:S1513-S1514
Estimated risk of radiation-induced cancer after thymoma treatments with proton- or x-ray beams
Lidestahl A; Johansson G; Siegbahn A; Lind PA
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(15):4053
Risk factors of metachronous peritoneal carcinomatosis after potentially curative gastric cancer resection in the CRITICS trial.
Caspers IA; Sikorska K; Slagter AE; Kranenbarg EM-K; Van de Velde CJH; Lind PA; Nordsmark M; Jansen EPM; Verheij M; van Sandick JW; Cats A; van Grieken NCT
Conference publication: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2019;105(1):E210
Perioperative Therapy with Postoperative Chemoradiotherapy in the Critics Gastric Cancer Trial: A Comparison of Elderly Versus Non-Elderly Patients
Slagter AE; Tudela B; van Amelsfoort RM; Sikorska K; Sandick JW; van de Velde CJ; van Grieken NC; Lind PA; Nordsmark M; Putter H; van Laarhoven HW; Grootscholten C; Kranenbarg EM-K; Jansen EPM; Cats A; Verheij M
Conference publication: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2019;105(1):S86
Patterns of Recurrence in the Critics Gastric Cancer Trial: Results from Intention-to-Treat and per-Protocol Analyses
van Amelsfoort RM; de Steur W; Sikorska K; Jansen EPM; Cats A; van Grieken NC; Boot H; Lind PA; Kranenbarg EM-K; Nordsmark M; Hartgrink H; Putter H; Trip AK; Sandick JW; van Tinteren H; Claassen YHM; Braak JPBM; van Laarhoven HW; van de Velde CJ; Verheij M
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(4):81
A comparison of elderly versus nonelderly patients in the CRITICS gastric cancer trial.
Slagter AE; Tudela B; van Amelsfoort R; Sikorska K; van Sandick JW; De Velde CJHV; van Grieken NCT; Lind PA; Nordsmark M; Putter H; Kranenbarg EM-K; Edwin PM
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(15):4060
Quality of life in the CRITICS study, a multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer.
Van Amelsfoort R; Walraven I; Jansen EPM; Cats A; van Grieken NCT; Aaronson NK; Boot H; Lind PA; Kranenbarg EM-K; Nordsmark M; Putter H; Trip AK; van Sandick JW; Sikorska K; van Tinteren H; Van De Velde CJH; Verheij M
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2018;127:S86-S87
Patterns of recurrence in the CRITICS gastric cancer phase III trial
Verheij M; Van Amelsfoort R; Sikorska K; Jansen E; Cats A; Van Grieken N; Boot H; Lind P; Kranenbarg EM-K; Nordsmark M; Hartgrink H; Putter H; Trip A; Van Sandick J; Van Tinteren H; Claassen Y; Braak J; Van de Velde C
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2018;127:S1092-S1093
Normal-tissue toxicity following gastric cancer radiotherapy with photon- or scanned proton-beams
Mondlane GA; Ureba A; Gubanski M; Lind P; Siegbahn A
Published conference paper: ACTA ONCOLOGICA. 2017;56(6):832-838
Comparison of gastric-cancer radiotherapy performed with volumetric modulated arc therapy or single-field uniform-dose proton therapy
Mondlane G; Gubanski M; Lind PA; Ureba A; Siegbahn A
Conference publication: PANCREAS. 2016;45(10):1529
ESPAC-4: A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma
Neoptolemos JP; Palmer D; Ghaneh P; Valle J; Cunningham D; Wadsley J; Meyer T; Anthoney A; Glimelius B; Falk S; Lind P; Izbicki J; Middleton G; Ross P; Wasan H; McDonald A; Crosby T; Psarelli E; Hammel P; Buechler MW
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15):4000
A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer: First results from the CRITICS study
Verheij M; Jansen EPM; Cats A; van Grieken NCT; Aaronson NK; Boot H; Lind PA; Kranenbarg EM-K; Nordsmark M; Putter H; Trip AK; van Sandick JW; Sikorska K; van Tinteren H; Van de Velde CJH
Review: CLINICAL GENITOURINARY CANCER. 2015;13(4):280-286
Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis
Nearchou A; Valachis A; Lind P; Akre O; Sandstrom P
Review: EJSO. 2015;41(3):282-294
Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: A direct and adjusted indirect comparison meta-analysis
Kumagai K; Rouvelas I; Tsai JA; Mariosa D; Lind PA; Lindblad M; Ye W; Lundell L; Schuhmacher C; Mauer M; Burmeister BH; Thomas JM; Stahl M; Nilsson M
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(15):e15567
Acquired hypothyroidism as a predictive marker of outcome in patients with metastatic renal cell carcinoma (mRCC) treated with tyrosine-kinase inhibitors (TKIs): A literature-based meta-analysis
Nearchou AD; Valachis A; Lind PA; Akre O; Sandstrom P
Review: BREAST CANCER RESEARCH AND TREATMENT. 2014;144(3):443-455
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis
Valachis A; Nearchou AD; Lind P
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(4):500
Acquired hypothyroidism as a predictive marker of outcome in patients with metastatic renal cell carcinoma (mRCC) treated with tyrosine-kinase inhibitors (TKIs): A literature-based meta-analysis.
Nearchou AD; Valachis A; Lind P; Akre O; Sandstrom P
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2013;31(15)
Cardiac toxicity in breast cancer patients treated with dual HER2 blockade: A meta-analysis of randomized evidence
Valachis A; Nearchou AD; Polyzos NP; Lind P
Review: ONCOLOGIST. 2013;18(4):353-361
Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis
Valachis A; Polyzos NP; Coleman RE; Gnant M; Eidtmann H; Brufsky AM; Aft R; Tevaarwerk AJ; Swenson K; Lind P; Mauri D
Conference publication: CANCER RESEARCH. 2012;72:p5-18-18-p5-18-18
Lapatinib versus trastuzumab, or both, added to preoperative chemotherapy for breast cancer: A meta-analysis of randomized evidence
Valachis A; Nearchou A; Lind P
Letter: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(31):3895
Role of Financial Relationships in Economic Analyses of Targeted Therapies in Oncology Remains Unclear Reply
Valachis A; Polyzos NP; Nearchou A; Lind P; Mauri D
Review: BREAST CANCER RESEARCH AND TREATMENT. 2012;135(3):655-662
Lapatinib, trastuzumab or the combination added to preoperative chemotherapy for breast cancer: a meta-analysis of randomized evidence
Valachis A; Nearchou A; Lind P; Mauri D
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(15)
Effect of BRCA mutation on prognosis in patients with ovarian cancer: A systematic review and meta-analysis
Valachis A; Polyzos NP; Zavos A; Mauri D; Lind PA
Conference publication: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2011;81(2):S211
Prognostic Significance of Histologically Proven Residual Tumor following Radical Radiotherapy
Ljung G; Valachis A; Nearchou A; Lind P; Nilsson S
Conference publication: EUROPEAN JOURNAL OF CANCER. 2011;47:S377
Adjuvant Therapy With Zoledronic Acid in Primary Breast Cancer: a Systematic Review and Meta-analysis
Valachis A; Nearchou A; Polyzos NP; Mauri D; Lind PA
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(15):1591
Time since last pregnancy and breast cancer survival: A systematic review and meta-analysis
Valachis A; Nearchou AD; Mauri D; Lind PA; Polyzos NP
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(15):6120
Conflict of interest in economic analyses of targeted therapies in oncology.
Nearchou AD; Valachis A; Polyzos NP; Mauri D; Lind PA
Meeting abstract: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2009;75(3):S213
Importance of Dosimetric Factors and Co-variates on Pulmonary Radiological Changes after Local-regional Radiotherapy (LRRT) for Breast Cancer (BC)
Lind PA; Blom-Goldman U; Svane G
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2008;26(15):4579
Final results of the randomized phase II study of sequential docetaxel and irinotecan with infusion 5-fluorouracil/folinic acid in patients with advanced gastric cancer - GA-TAC
Lind PA; Gubanski M; Johnsson A; Fernebro E; Flygare P; Karlberg I; Kadar L; Glimelius B
Published conference paper: ACTA ONCOLOGICA. 2008;47(3):413-420
Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma
Lind PA; Isaksson B; Almstrom M; Johnsson A; Albiin N; Bystrom P; Permert J
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2007;25(18)
Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma
Lind PA; Isaksson B; Almstrom M; Johnsson A; Albiin N; Bystrom P; Permert J
Review: ACTA ONCOLOGICA. 2007;46(3):277-285
Advances in the treatment of patients with gastric adenocarcinoma
Foukakis T; Lundell L; Gubanski M; Lind PA
Meeting abstract: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006;66(3):S487
Heart changes on MRI and spect after definitive radiation therapy in patients with lung cancer
Lind PA; Larsson T; Lidestahl A; Agren-Cronqvist A; Nygren A; Brodin O
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006;64(3):765-770
ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer
Lind PA; Wennberg B; Gagliardi G; Rosfors S; Blom-Goldman U; Lideståhl A; Svane G
Letter: ACTA ONCOLOGICA. 2006;45(2):210-212
Reassessment for radical surgery after palliative chemotherapy in locally advanced pancreatic carcinoma:: Two case-reports
Lideståhl A; Permert J; Linder S; Bylund H; Edsborg N; Lind P
Review: ACTA ONCOLOGICA. 2006;45(2):136-143
Efficacy of systemic therapy in advanced pancreatic carcinoma
Lideståhl A; Permert J; Linder S; Bylund H; Edsborg N; Lind P
Editorial comment: ACTA ONCOLOGICA. 2006;45(1):13-15
Clinical relevance of pulmonary toxicity in adjuvant breast cancer irradiation
Lind P
Meeting abstract: RADIOTHERAPY AND ONCOLOGY. 2005;76:S48
Radiation induced pulmonary complications in breast cancer patients clinically and radiologically scored: NTCP fit with four different models
Gagliardi G; Rancati T; Wennberg B; Svane G; Lind P
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2005;63(1):214-223
The incidence and functional consequences of RT-associated cardiac perfusion defects.
Marks LB; Yu X; Prosnitz RG; Zhou S-M; Hardenbergh PH; Blazing M; Hollis D; Lind P; Tisch A; Wong TZ; Borges-Neto S
Published conference paper: ACTA ONCOLOGICA. 2005;44(3):236-239
Capecitabine as third line therapy in patients with advanced colorectal cancer
Gubanski M; Naucler G; Almerud A; Lideståhl A; Lind PARM
Conference publication: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2004;60(1):S401
Effect of dose-volume constraints on pneumonitis in loco-regional breast cancer irradiation
Blom-Goldman U; Anderson M; Wennberg B; Svane G; Lind P
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2004;22(14):50S
Prevention of radiation pneumonitis in breast cancer irradiation through dose-volume constraints.
Lind P; Blom-Goldman U; Anderson M; Wennberg B; Svane G
Conference publication: BREAST CANCER RESEARCH AND TREATMENT. 2004;88:S173
Assessment of pneumonitis in loco-regional breast cancer irradiation.
Blom-Goldman U; Andersson M; Wennberg B; Svane G; Lind P
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2003;55(5):1196-1199
Breast conservation rates-barriers between tertiary care and community practice.
Hahn CA; Marks LB; Chen DY; Lind PA; Lind HM; Prosnitz LR
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2003;55(4):914-920
Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution.
Lind PA; Pagnanelli R; Marks LB; Borges-Neto S; Hu C; Zhou SM; Light K; Hardenbergh PH
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2002;54(2):340-347
Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury.
Lind PA; Marks LB; Hollis D; Fan M; Zhou S-M; Munley MT; Shafman TD; Jaszczak RJ; Coleman RE
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2002;52(1):137-143
Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer.
Lind PARM; Marks LB; Hardenbergh PH; Clough R; Fan M; Hollis D; Hernando ML; Lucas D; Piepgrass A; Prosnitz LR
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2001;51(2):311-317
Relating radiation-induced regional lung injury to changes in pulmonary function tests.
Fan M; Marks LB; Lind P; Hollis D; Woel RT; Bentel GG; Anscher MS; Shafman TD; Coleman RE; Jaszczak RJ; Munley MT
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2000;46(2):373-381
Radiation pneumonitis after breast cancer irradiation:: Analysis of the complication probability using the relative seriality model
Gagliardi G; Bjöhle J; Lax I; Ottolenghi A; Eriksson F; Liedberg A; Lind P; Rutqvist LE
Doctoral thesis: 1999
Short-term pulmonary side-effects following radiation therapy in breast cancer
Lind P
Published conference paper: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 1999;43(3):489-496
Abnormalities by pulmonary regions studied with computer tomography following local or local-regional radiotherapy for breast cancer
Lind PARM; Svane G; Gagliardi G; Svensson C
Visa fler

Forskningsbidrag

AI in radiation therapy
Regional Cancercentrum Stockholm
30 April 2024 - 31 December 2025
STAR-TReC
Cancerfonden
1 August 2023 - 1 August 2027
Support STAR-TReC
ALF Region Stockholm
31 January 2023 - 31 December 2027
CITCCA-Circulating Tumour DNA in Colorectal Cancer- a pilot study
Swedish Research Council
1 January 2020 - 31 December 2020
Support STAR-TReC
Regional Cancer Centrum

Anställningar

Anknuten till Forskning, Klinisk forskning och utbildning, Södersjukhuset, Karolinska Institutet, 2025-2028
Anknuten till Forskning, Klinisk forskning och utbildning, Södersjukhuset, Karolinska Institutet, 2023-2026
Adjungerad Lektor, Klinisk forskning och utbildning, Södersjukhuset, Karolinska Institutet, 2024-2024

Examina och utbildning

Docent, Karolinska Institutet, 2003
MEDICINE DOKTORSEXAMEN, Institutionen för klinisk forskning o utbildning, Södersjukhuset, Karolinska Institutet, 1999

Om mig

Forskningsbeskrivning

Undervisning

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI